Daniel I. S. Rosenbloom

发表

Designing and interpreting limiting dilution assays: general principles and applications to the latent reservoir for HIV-1

Alison L. Hill, Daniel I. S. Rosenbloom, Oliver Elliott, 2015, bioRxiv.

Imitation dynamics of vaccination behaviour on social networks

Daniel I. S. Rosenbloom, M. Nowak, Long Wang, 2011, Proceedings of the Royal Society B: Biological Sciences.

Imperfect drug penetration leads to spatial monotherapy and rapid evolution of multidrug resistance

Daniel I. S. Rosenbloom, M. Nowak, D. Petrov, 2014, Proceedings of the National Academy of Sciences.

Predicting the outcomes of treatment to eradicate the latent reservoir for HIV-1

Feng Fu, Martin A Nowak, Daniel I. S. Rosenbloom, 2014, Proceedings of the National Academy of Sciences.

Re-evaluating evolution in the HIV reservoir

Alison L. Hill, Sarah B. Laskey, Robert F. Siliciano, 2017, Nature.

Antiretroviral dynamics determines HIV evolution and predicts therapy outcome

Martin A. Nowak, Alison L. Hill, Robert F. Siliciano, 2012, Nature Medicine.

Evolutionary dynamics of HIV at multiple spatial and temporal scales

Daniel I. S. Rosenbloom, M. Nowak, A. Hill, 2012, Journal of Molecular Medicine.

Assessing intra-lab precision and inter-lab repeatability of outgrowth assays of HIV-1 latent reservoir size

Daniel I. S. Rosenbloom, Michele D. Sobolewski, R. Ptak, 2019, PLoS computational biology.

Correction: Real-Time Predictions of Reservoir Size and Rebound Time during Antiretroviral Therapy Interruption Trials for HIV

Emily B Hanhauser, Daniel I. S. Rosenbloom, R. Siliciano, 2016, bioRxiv.

Preliminary Acceptability of a Home-Based Peripheral Blood Collection Device for Viral Load Testing in the Context of Analytical Treatment Interruptions in HIV Cure Trials: Results from a Nationwide Survey in the United States

Daniel I. S. Rosenbloom, D. Hazuda, L. Montaner, 2022, Journal of personalized medicine.

Proliferation of latently infected CD4+ T cells carrying replication-competent HIV-1: Potential role in latent reservoir dynamics

Daniel I. S. Rosenbloom, R. Siliciano, J. Siliciano, 2017, The Journal of experimental medicine.

Replication-Competent Noninduced Proviruses in the Latent Reservoir Increase Barrier to HIV-1 Cure

Sarah B. Laskey, Robert F. Siliciano, Daniel I. S. Rosenbloom, 2013, Cell.

Insight into treatment of HIV infection from viral dynamics models

Martin A Nowak, Daniel I. S. Rosenbloom, Alison L Hill, 2018, Immunological reviews.

Allogeneic bone marrow transplantation with post-transplant cyclophosphamide for patients with HIV and haematological malignancies: a feasibility study.

Daniel I. S. Rosenbloom, R. Siliciano, J. Gallant, 2020, The lancet. HIV.

Allogeneic Bone Marrow Transplant for HIV Patients with Hematologic Malignancies with Post-transplant Cyclophosphamide: a Feasibility Study

Daniel I. S. Rosenbloom, R. Siliciano, J. Gallant, 2020 .

Rapid Seeding of the Viral Reservoir Prior to SIV Viremia in Rhesus Monkeys

Jinyan Liu, Merlin L. Robb, Alison L. Hill, 2014, Nature.

Real-Time Predictions of Reservoir Size and Rebound Time during Antiretroviral Therapy Interruption Trials for HIV

Emily B Hanhauser, Emily Hanhauser, Daniel I. S. Rosenbloom, 2016, PLoS pathogens.

Ex vivo analysis identifies effective HIV-1 latency-reversing drug combinations.

Daniel I. S. Rosenbloom, Alison L Hill, R. Siliciano, 2015, The Journal of clinical investigation.

Correction: Real-Time Predictions of Reservoir Size and Rebound Time during Antiretroviral Therapy Interruption Trials for HIV

Emily B Hanhauser, Daniel I. S. Rosenbloom, R. Siliciano, 2017, PLoS pathogens.

Designing and Interpreting Limiting Dilution Assays: General Principles and Applications to the Latent Reservoir for Human Immunodeficiency Virus-1

Daniel I. S. Rosenbloom, R. Siliciano, T. Henrich, 2015, Open forum infectious diseases.

Measuring the Frequency of Latent HIV-1 in Resting CD4⁺ T Cells Using a Limiting Dilution Coculture Assay.

Daniel I. S. Rosenbloom, R. Siliciano, J. Siliciano, 2016, Methods in molecular biology.

Insufficient Evidence for Rare Activation of Latent HIV in the Absence of Reservoir-Reducing Interventions

Daniel I. S. Rosenbloom, R. Siliciano, J. Siliciano, 2016, PLoS pathogens.

Assessing intra-lab precision and inter-lab repeatability of outgrowth assays of HIV-1 latent reservoir size

Michael P. Busch, Jun Lai, John W. Mellors, 2018, bioRxiv.

Assessing suitability of next-generation viral outgrowth assays as proxies for classic QVOA to measure HIV-1 latent reservoir size.

Daniel I. S. Rosenbloom, R. Ptak, D. Richman, 2020, Journal of Infectious Diseases.

Corrections: Predicting the outcomes of treatment to eradicate the latent reservoir for HIV-1 (Proc Natl Acad Sci USA (2014) 111, (13475-13480) doi: 10.1073/pnas.1406663111)

Daniel I. S. Rosenbloom, R. Siliciano, M. Nowak, 2014 .

Asymptomatic Shedding of Respiratory Virus among an Ambulatory Population across Seasons

Daniel I. S. Rosenbloom, R. DeSalle, J. Shaman, 2018, mSphere.

Life cycle synchronization is a viral drug resistance mechanism

Martin A. Nowak, Mark Freeman, Daniel I. S. Rosenbloom, 2018, PLoS Comput. Biol..

Assessing the Suitability of Next-Generation Viral Outgrowth Assays to Measure Human Immunodeficiency Virus 1 Latent Reservoir Size

Daniel I. S. Rosenbloom, R. Ptak, D. Richman, 2020, The Journal of Infectious Diseases.

Safety, efficacy, and immunogenicity of a replication-defective human cytomegalovirus vaccine, V160, in cytomegalovirus-seronegative women: a double-blind, randomised, placebo-controlled, phase 2b trial.

Daniel I. S. Rosenbloom, K. Russell, M. Ritter, 2023, The Lancet. Infectious diseases.

Imitation dynamics of vaccination behaviour on social Supplementary data tml

Daniel I. S. Rosenbloom, Feng Fu, Martin A. Nowak, 2010 .